The diagnosis and management of hereditary spherocytosis

P H Bolton-Maggs1

  • 1Royal Liverpool Children's Hospital, Liverpool, UK.

Insights

Hereditary spherocytosis (HS) is a common blood disorder, often diagnosed easily. Management varies from watchful waiting for mild cases to splenectomy for severe hereditary spherocytosis.

Area of Science:

  • Hematology
  • Genetics
  • Pediatric Medicine

Background:

  • Hereditary spherocytosis (HS) is a prevalent genetic hemolytic anemia.
  • Most Caucasian individuals present with mild to moderate disease.
  • Diagnosis is typically clinical, but atypical cases require advanced testing.

Purpose of the Study:

  • To outline the diagnostic approaches for hereditary spherocytosis.
  • To detail management strategies based on disease severity.
  • To emphasize the importance of differentiating HS from conditions like stomatocytosis.

Main Methods:

  • Clinical presentation and family history review.
  • Laboratory tests including membrane protein analysis.
  • Molecular genetics for complex cases.
  • Surgical intervention considerations, specifically splenectomy.

Main Results:

  • Mild HS managed conservatively without splenectomy or folate supplements.
  • Splenectomy benefits moderate to severe HS cases, recommended after age 6.
  • Ruling out stomatocytosis is critical due to splenectomy contraindications.

Conclusions:

  • Accurate diagnosis of hereditary spherocytosis is key for appropriate management.
  • Splenectomy is a viable option for severe HS, with careful pre-operative counseling.
  • Laparoscopic splenectomy offers benefits like reduced hospital stay and pain.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...